Apremilast in refractory orogenital ulcers and other manifestations of Beh çet's disease. A national multicentre study of 51 cases in clinical practice.
CONCLUSIONS: APR yielded a rapid and maintained improvement of refractory mucocutaneous ulcers of BD, even in patients refractory to several systemic drugs including biologic therapy.
PMID: 33331268 [PubMed - in process]
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research
More News: Arthritis | Brain | Neurology | Prednisone | Psoriasis | Rheumatology | Skin | Spain Health | Study | Thrombosis | Women